ResMed Revenue 2006-2018 | RMD

ResMed annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ResMed revenue for the quarter ending December 31, 2018 was $0.651B, a 8.29% increase year-over-year.
  • ResMed revenue for the twelve months ending December 31, 2018 was $2.455B, a 11.79% increase year-over-year.
  • ResMed annual revenue for 2018 was $2.34B, a 13.23% increase from 2017.
  • ResMed annual revenue for 2017 was $2.067B, a 12.4% increase from 2016.
  • ResMed annual revenue for 2016 was $1.839B, a 9.52% increase from 2015.
ResMed Annual Revenue
(Millions of US $)
2018 $2,340
2017 $2,067
2016 $1,839
2015 $1,679
2014 $1,555
2013 $1,514
2012 $1,369
2011 $1,243
2010 $1,092
2009 $921
2008 $835
2007 $716
2006 $607
2005 $426
ResMed Quarterly Revenue
(Millions of US $)
Q2 2018 $651
Q1 2018 $588
Q4 2018 $624
Q3 2018 $592
Q2 2017 $601
Q1 2017 $524
Q4 2017 $557
Q3 2017 $514
Q2 2016 $530
Q1 2016 $465
Q4 2016 $519
Q3 2016 $454
Q2 2015 $455
Q1 2015 $412
Q4 2015 $453
Q3 2015 $422
Q2 2014 $423
Q1 2014 $380
Q4 2014 $415
Q3 2014 $398
Q2 2013 $384
Q1 2013 $358
Q4 2013 $415
Q3 2013 $384
Q2 2012 $377
Q1 2012 $340
Q4 2012 $372
Q3 2012 $349
Q2 2011 $333
Q1 2011 $315
Q4 2011 $342
Q3 2011 $313
Q2 2010 $306
Q1 2010 $282
Q4 2010 $292
Q3 2010 $279
Q2 2009 $275
Q1 2009 $247
Q4 2009 $252
Q3 2009 $228
Q2 2008 $223
Q1 2008 $218
Q4 2008 $235
Q3 2008 $212
Q2 2007 $203
Q1 2007 $186
Q4 2007 $191
Q3 2007 $183
Q2 2006 $178
Q1 2006 $164
Q4 2006 $171
Q3 2006 $162
Q2 2005 $146
Q1 2005 $127
Q4 2005 $125
Q3 2005 $108
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.383B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.272B 27.73
Medtronic (MDT) Ireland $125.787B 18.39
Stryker (SYK) United States $72.312B 26.54
Boston Scientific (BSX) United States $55.730B 27.17
Baxter (BAX) United States $39.435B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.742B 16.48
Smith & Nephew SNATS (SNN) United Kingdom $17.346B 0.00
Canopy Growth (CGC) Canada $15.357B 0.00
Aurora Cannabis (ACB) Canada $9.728B 68.64
Bio-Rad Laboratories (BIO) United States $9.298B 53.05
Hill-Rom Holdings (HRC) United States $6.949B 21.49
Perrigo (PRGO) Ireland $6.542B 10.61
Insulet (PODD) United States $5.812B 1960.80
GW Pharmaceuticals (GWPH) United Kingdom $5.107B 0.00
ICU Medical (ICUI) United States $4.771B 29.70
Haemonetics (HAE) United States $4.422B 39.23
Agios Pharmaceuticals (AGIO) United States $3.796B 0.00
Hutchison China MediTech (HCM) China $3.712B 0.00
Neogen (NEOG) United States $3.240B 49.77
NuVasive (NUVA) United States $2.859B 24.94
Quidel (QDEL) United States $2.688B 24.25
Aphria (APHA) $2.403B 106.67
National Vision Holdings (EYE) United States $2.385B 46.92
Cardiovascular Systems (CSII) United States $1.382B 992.25
Phibro Animal Health (PAHC) United States $1.275B 18.33
VAREX IMAGING (VREX) United States $1.255B 24.57
AtriCure (ATRC) United States $1.121B 0.00
MacroGenics (MGNX) United States $0.933B 0.00
Lantheus Holdings (LNTH) United States $0.929B 25.10
NanoString Technologies (NSTG) United States $0.855B 0.00
Cerus (CERS) United States $0.838B 0.00
PetIQ (PETQ) United States $0.787B 22.53
Omeros (OMER) United States $0.786B 0.00
OraSure Technologies (OSUR) United States $0.721B 31.62
Surmodics (SRDX) United States $0.703B 102.18
Meridian Bioscience (VIVO) United States $0.701B 20.89
Evolus (EOLS) United States $0.677B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 22.28
LeMaitre Vascular (LMAT) United States $0.614B 29.22
TG Therapeutics (TGTX) United States $0.607B 0.00
Quanterix (QTRX) United States $0.552B 0.00
BioLife Solutions (BLFS) United States $0.346B 143.85
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.323B 21.01
Insys Therapeutics (INSY) United States $0.308B 0.00
Owens & Minor (OMI) United States $0.301B 4.17
Rockwell Medical (RMTI) United States $0.297B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.269B 0.00
Bovie Medical (APYX) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Fonar (FONR) United States $0.146B 7.81
Zynex (ZYXI) United States $0.142B 15.14
Surface Oncology (SURF) United States $0.131B 0.00
Chimerix (CMRX) United States $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 18.64
Conatus Pharmaceuticals (CNAT) United States $0.081B 0.00
Trinity Biotech (TRIB) Ireland $0.073B 21.79
CAS Medical Systems (CASM) United States $0.072B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.026B 0.00
Capricor Therapeutics (CAPR) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14